Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate
While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac’s and Sinopharm Group’s shots, which have been widely used in the developing world.
China's vaccine diplomacy drive falters as recipients turn to western shots
In the early days of COVID-19 vaccine rollouts, Chinese shots saved countless lives. But as the Western stranglehold on mRNA supplies loosens, a clear preference has emerged.
Many Brazilians insist on Pfizer even as nation passes 500,000 COVID-19 deaths
In Sao Paulo, people demand the U.S. company’s shots at public clinics and often walk out if none are available.
Chinese shot takes controversial path to vaccinating the world
Used to operating within China, where public opinion is censored, Chinese vaccine-makers have had a tough time showing their "growth in front of the world," an expert said.
China’s Sinovac shot found highly effective in real world study
Indonesian data adds to signs out of Brazil that the shot is more effective than it proved in the testing phase, which was beset by divergent efficacy rates and questions over transparency.
WHO approves Sinopharm vaccine in potential boost to COVAX pipeline
The vaccine, one of two main Chinese coronavirus vaccines, is the first developed by a non-Western country to win WHO backing.
The world turns to China for vaccines after India and U.S. stumble
Some experts are worried about the potential impact of widely deploying Chinese shots that have demonstrated lower efficacy rates than those made by Pfizer and Moderna.
Hong Kong offers a masterclass in vaccine confusion
Hong Kong was always going to struggle to run a mass vaccination campaign.
Hong Kong vaccine rollout hampered by reliance on Chinese shots
Confidence in both the Sinovac shot and the government’s vaccine drive has plummeted.
Prime Minister Prayuth Chan-ocha is expected to be among the first to receive the vaccine this weekend.
China’s COVID-19 vaccine drive is falling behind the U.S. and Europe
The slowness appears to be due to widespread hesitation in the country, including lingering safety concerns, doubts about the level of protection promised and a general lack of urgency.
'I won’t take it': China struggles to get the world to trust its vaccines
That uncertainty presents another roadblock in China’s efforts to extend its political influence across Asia, Africa and South America.
